RSCM
Rock Springs Capital Management’s Xenon Pharmaceuticals XENE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.2M | Hold |
931,681
| – | – | 1.82% | 21 |
|
|
2025
Q1 | $31.3M | Sell |
931,681
-320,178
| -26% | -$10.7M | 1.79% | 18 |
|
|
2024
Q4 | $49.1M | Sell |
1,251,859
-64,618
| -5% | -$2.53M | 1.87% | 17 |
|
|
2024
Q3 | $51.8M | Buy |
1,316,477
+43,600
| +3% | +$1.72M | 1.69% | 17 |
|
|
2024
Q2 | $49.6M | Buy |
1,272,877
+17,300
| +1% | +$675K | 1.49% | 25 |
|
|
2024
Q1 | $54.1M | Hold |
1,255,577
| – | – | 1.37% | 26 |
|
|
2023
Q4 | $57.8M | Buy |
1,255,577
+77,575
| +7% | +$3.57M | 1.42% | 22 |
|
|
2023
Q3 | $40.2M | Hold |
1,178,002
| – | – | 1.08% | 31 |
|
|
2023
Q2 | $45.4M | Hold |
1,178,002
| – | – | 1.08% | 32 |
|
|
2023
Q1 | $42.2M | Buy |
1,178,002
+2,330
| +0.2% | +$83.4K | 1.01% | 34 |
|
|
2022
Q4 | $46.4M | Buy |
1,175,672
+19,711
| +2% | +$777K | 1.12% | 32 |
|
|
2022
Q3 | $41.7M | Buy |
1,155,961
+32,357
| +3% | +$1.17M | 1.08% | 31 |
|
|
2022
Q2 | $34.2M | Buy |
1,123,604
+281,106
| +33% | +$8.55M | 0.99% | 33 |
|
|
2022
Q1 | $25.8M | Buy |
842,498
+71,131
| +9% | +$2.17M | 0.65% | 52 |
|
|
2021
Q4 | $24.1M | Buy |
771,367
+188,267
| +32% | +$5.88M | 0.56% | 58 |
|
|
2021
Q3 | $8.91M | Buy |
583,100
+10,600
| +2% | +$162K | 0.19% | 111 |
|
|
2021
Q2 | $10.7M | Hold |
572,500
| – | – | 0.21% | 109 |
|
|
2021
Q1 | $10.2M | Buy |
572,500
+57,500
| +11% | +$1.03M | 0.22% | 112 |
|
|
2020
Q4 | $7.92M | Sell |
515,000
-711
| -0.1% | -$10.9K | 0.17% | 122 |
|
|
2020
Q3 | $5.71M | Hold |
515,711
| – | – | 0.14% | 124 |
|
|
2020
Q2 | $6.47M | Buy |
515,711
+15,711
| +3% | +$197K | 0.18% | 122 |
|
|
2020
Q1 | $5.67M | Buy |
+500,000
| New | +$5.67M | 0.23% | 92 |
|